Concepedia
1
Publications
10
Citations
H-Index
2012
Active since
Affiliations
Synta Pharmaceuticals (United States)(Current)
Chris Borella is an author at Synta Pharmaceuticals (United States).
Publications per year
2012–2012
The Vascular Disrupting Agent STA-9584 Exhibits Potent Antitumor Activity by Selectively Targeting Microvasculature at Both the Center and Periphery of Tumors
Kevin P. Foley, Dan Zhou, Chris Borella et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 10 citations
Rows per page
1–1 of 1